Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(34/35): 1686
DOI: 10.1055/s-0029-1234001
DOI: 10.1055/s-0029-1234001
Pro & Contra | Commentary
Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York
Immunsuppression bei membranöser Glomerulonephritis – Pro
Immunosuppression in membranous glomerulonephritis – proFurther Information
Publication History
Publication Date:
25 August 2009 (online)
Schlüsselwörter
membranöse Glomerulonephritis - Immunsuppression
Keywords
membranous nephropathy - immunosuppression
Literatur
- 1 Beck L H, Bonegio R G, Lambeau G. et al . M-type phosholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009; 361 11-21
- 2 Bomback A S, Derebail V K, McGregor J G. et al . Rituximab therapy for membranous nephropathy: A systematic review. CJASN. 2009; 4 734-744
- 3 Cattran D. Management of membranous nephropathy: When and what for treatment?. JASN. 2005; 16 1188-1194
- 4 Debiec H, Guigonis V, Mougenot B. et al . Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002; 346 2053-2060
- 5 Kerjaschki D. Pathomechanisms and molecular basis of membranous glomerulonephritis. Lancet. 2004; 364 1194-1196
Prof. Dr. Rolf A. K. Stahl
III. Medizinische Klinik, Universitätsklinikum
Hamburg-Eppendorf
Martinistr. 52
20246 Hamburg